CALIDI BIOTHERAPEUTICS, INC.

Profile

Company Names

CALIDI BIOTHERAPEUTICS, INC.

Addresses

4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA 92121

Phone Numbers

858-794-9600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$4,999,975.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2023-06-20 
$4,999,975.00 
$25,000,000.00 
$20,000,025.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALLAN 
 
CAMAISA 
EXECUTIVE OFFICER, DIRECTOR
CALIDI BIOTHERAPEUTICS, INC.   |  CALIDI BIOTHERAPEUTICS, INC.
TONY 
 
KALAJIAN 
EXECUTIVE OFFICER
CALIDI BIOTHERAPEUTICS, INC.
HEEHYOUNG 
 
LEE 
DIRECTOR
CALIDI BIOTHERAPEUTICS, INC.
SCOTT 
 
LEFTWICH 
DIRECTOR
CALIDI BIOTHERAPEUTICS, INC.   |  CALIDI BIOTHERAPEUTICS, INC.
BORIS 
 
MINEV 
EXECUTIVE OFFICER
CALIDI BIOTHERAPEUTICS, INC.   |  CALIDI BIOTHERAPEUTICS, INC.
GEORGE 
 
NG 
DIRECTOR
MORPHOGENESIS INC   |  GGWP, INC.   |  CALIDI BIOTHERAPEUTICS, INC.   |  TUHURA BIOSCIENCES, INC.   |  CALIDI BIOTHERAPEUTICS, INC.   |  TUHURA BIOSCIENCES, INC./NV
AMISH 
 
PATEL 
EXECUTIVE OFFICER
PAN TERRA INDUSTRIES INC   |  UNIFIED CML OPERATIONS, LLC   |  KATALYST INC.   |  THIRD EYE HEALTH, INC.   |  IRC PARENT, INC.   |  ELECTUS INVESTMENT FUND I, LLC   |  ASSISTED 4 LIVING, INC.   |  CALIDI BIOTHERAPEUTICS, INC.   |  CONDUIT VENTURE LABS HOLDINGS I, LLC
WENDY 
 
PIZARRO 
EXECUTIVE OFFICER
CALIDI BIOTHERAPEUTICS, INC.   |  CALIDI BIOTHERAPEUTICS, INC.
DAVID 
 
SANS 
EXECUTIVE OFFICER
CALIDI BIOTHERAPEUTICS, INC.
ANTHONY 
F. 
SANTIDRIAN 
EXECUTIVE OFFICER
CALIDI BIOTHERAPEUTICS, INC.
JAMES 
 
SCHOENECK 
DIRECTOR
ALTHEUS THERAPEUTICS INC   |  CALIDI BIOTHERAPEUTICS, INC.
STEPHEN 
 
THESING 
EXECUTIVE OFFICER
CALIDI BIOTHERAPEUTICS, INC.
ALFONSO 
 
ZULUETA 
DIRECTOR
CALIDI BIOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ARCADIA SECURITIES, LLC
44656